Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Soraya Berjaya Indonesia Tbk. (SPRE) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Soraya Berjaya Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Soraya Berjaya Indonesia Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Soraya Berjaya Indonesia Tbk. trades at Rp83 (market cap 60.8B, 760.3K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 5.1× Soraya Berjaya Indonesia Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 760.3K). Which is the better fit depends on your goals.

DGNSSPRE
Market Cap
310.75B60.8B
Volume
963.6K760.3K
Lot
9.64K7.6K
Turnover
217.67M62.04M
Average Price
225.8981.6
Value
217.67M62.04M
Indicative Equilibrium Price
22683
Indicative Equilibrium Volume
1K17

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
SPRE
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Soraya Berjaya Indonesia Tbk.

PT. Soraya Berjaya Indonesia (Company) was established based on Deed No. 05 dated March 05, 2015 by Notary Martalena, S.H., in Padang. Perseroan memulai kegiatan komersilnya pada tahun 2015. dengan mengoperasikan menggunakan merek dagang Soraya Bed Sheet.

Read more on SPRE